NantHealth, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.25
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.09
|
-0.12
|
-0.03
|
-33.33%
|
|
2022-06-30
|
-0.09
|
-1.50
|
-1.41
|
-1566.67%
|
|
2022-03-31
|
-0.09
|
-1.65
|
-1.56
|
-1733.33%
|
|
2021-12-31
|
-0.08
|
-1.50
|
-1.42
|
-1775.00%
|
|
2021-09-30
|
-0.08
|
-1.50
|
-1.42
|
-1775.00%
|
|
2021-06-30
|
-0.09
|
-1.20
|
-1.11
|
-1233.33%
|
|
2021-03-31
|
-0.07
|
-1.35
|
-1.28
|
-1828.57%
|
|
2020-12-31
|
-0.08
|
-0.90
|
-0.82
|
-1025.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.27
|
|
2021-12-31
|
-5.55
|
|
2020-12-31
|
-1.10
|
|
2019-12-31
|
-0.25
|
|
2018-12-31
|
-0.40
|
|
2017-12-31
|
-0.62
|
|
2016-12-31
|
-0.51
|